Brian Leyland-Jones

Kealey Bultena / SDPB

Avera’s work to personalize cancer treatment could help people around the world. Leaders for the health system made the announcement Tuesday that the genomic oncology team is joining with the Worldwide Innovative Networking Consortium to participate in research and clinical trials. Now internationally renowned cancer expert Doctor Brian Leyland-Jones and Avera’s Center for Precision Oncology Director Casey Williams talk about the potential that exists in the new partnership.

Kealey Bultena / SDPB

Cancer researchers in Sioux Falls are now part of an international group collaborating on personalized treatment. Avera Cancer Institute is one of five American institutions partnering in a consortium referred to as WIN. Doctors say the revelations can help people with cancer at all stages.

Standard cancer treatments are often based on therapies that work for most people. Doctor Brian Leyland-Jones says everyone is different – and so are their cancers. He says tumors have different genes, compositions and signaling pathways.